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Abstract 
In tissue engineering, biomaterials play a critical role, act as a 3D 
template, provide mechanical support, and give artificial extracellular matrix 
environment (ECM) for neo-tissue formation. Only one type of biomaterials 
is not enough for both hard and soft tissue engineering. That’s why all types 
of biomaterials i.e. metals, ceramics, & polymers have their own importance 
in making tissue engineering scaffolds. This article presents a brief overview 
on all types of biomaterials (metals, ceramics, natural and synthetic 
polymers, composite materials, & hydrogels) that are being developed for 
soft or hard tissue engineering with their properties, limitations, current 
developments and future challenges in tissue engineering applications. This 
article also represents brief discussion on tissue engineering triad i.e. 
scaffolds, signal, & cells.  
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Introduction 
In the human body, degeneration of tissues or tissue defects may 
occur due to diseases, trauma, accidents, aging or congenital defects, in 
which case treatments are necessary to facilitate the tissues repair, 
regeneration or replacement (Fergal, 2011). Typical treatments focus on 
organ or tissue transplantation as an autograft, allograft, and sometimes 
isograft & xenograft. Harvesting autografts (obtained from the host), depend 
on blood supply & need to avoid visceral injuries (Mekala, 2012), where 
allografts (from one individual to another in the same species) & xenografts 
(obtained from another species) own the problems associated with infection 
or disease transmission and immune rejection of the implants (Flanagan, 
2006). Another problem with these treatments is dearth of organ donor. 
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Today tissue engineering has emerged as a rapidly expanding approach to 
overcome the drawbacks with these classical treatments by regenerating 
damaged tissues, instead of replacing them (Fergal, 2011 & Mekala, 2012). 
This approach lead to the development of biomaterials to prepare porous 3D 
scaffolds as biological substitutes to restore, maintain, or improve defective 
tissues (B.P. Chan, 2008 & Karp, 2007).Various materials including metals, 
natural and synthetic polymers, ceramics and even their composites have 
been developed as tissue engineering scaffolds. While bioceramics & 
polymers are suitable for bone tissue engineering as native bone consists of a 
naturally occuring polymer and biological apatite, but ceramics are brittle 
and polymers do not show enough mechanical properties which limited their 
applications in load-bearing areas. In contrast, metals are suitable for load-
bearing applications because of their high mechanical strength. But metals 
are bio-inert, generally lack biodegradability and are not suitable for soft 
tissue engineering. On the other hand, hydrogels synthesized by ionic or 
covalent cross-linking can encapsulate proteins or bioactive molecules and 
release them by a mechanism manipulated by swelling of the hydrogels 
(Berger, 2004). So selection of appropriate scaffolding materials is necessary 
for successful tissue engineering. 
 
Tissue engineering: An overview 
In 1988, the National Science Foundation Workshop first coined the 
term ‘Tissue Engineering’ to mean “the application of principles and 
methods of engineering and life sciences toward the fundamental 
understanding of structure-function relationships in normal and pathological 
mammalian tissues & the development of biological substitutes to restore, 
maintain, or improve tissue function” (Skalak, 1989). Since then, as a new 
discipline and potential medical treatment, tissue engineering has made rapid 
advances that holds promises of  (1) eliminating re-operations by using 
biological substitutes which are biodegradable, (2)solve problems of immune 
rejection of implants, infections or diseases transmission associated with 
allografts & xenografts , and shortage of organ donation, (3) initiating the 
natural regeneration process with biological substitutes to repair or replace  
lost or damaged tissues i.e. to provide long term solutions, (4) offering 
potential treatments for currently untreatable medical conditions (Zippel, 
2010 & Min Wang 2006). Tissue engineering strategies involve combining 
living cells with a natural/synthetic support or scaffold to develop a 
biological substitute or 3D living construct which is structurally, 
mechanically and functionally equal to or better than the tissue that is to be 
replaced (Zippel N, 2010 & K.M. Kim, 2005). To develop such tissue 
engineering construct requires careful selection of three major components: 
(1) scaffolds, (2) signaling factors, & (3) cells (Brochhausen, ISBN:978-953-
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307-079-7); generally referred to as tissue engineering triad (B.P. Chan, 
2004). Porous 3D scaffolds are generally seeded with cells and occasionally 
with signaling molecules or subjected to biophysical stimuli in the form of a 
bioreactor (I.Martin, 2004). These cell-seeded scaffolds are either undergo a 
pre-implantation differentiation culture in vitro, to synthesize tissues and 
then transplanted or are directly implanted into the injured site, using the 
body’s own systems, where tissue regeneration is induced in vivo (Fergal, 
2011). The general tissue engineering approaches with porous scaffolds are 
shown in below by figure 1. 
 
Figure 1:  Tissue engineering (nuhs.edu.sg) 
 
Scaffold: Tissue engineering scaffolds mimic the 3D environment of 
the natural extracellular matrix (ECM), provide short term mechanical 
support of the transplant, & provide an increased surface area for cells 
adhesion, proliferation, migration, and differentiation, eventually leading to 
neo-tissue formation (Zippel, 2010). As blood vessels grow into the new 
tissue, the scaffold degrades and replaced by the new tissue (Zippel, 2010). 
 
Key factors concerning scaffolds for use in tissue engineering 
Biocompatibility: In case of tissue engineering, the biocompatibility 
of a scaffold or an artificial ECM refers to the ability to perform as a 3D 
substrate that will possess the right surface chemistry (with the faciliation of 
molecular and mechanical signaling system) to promote cell adhesion, 
proliferation, and migration in vitro (Wang HM, Chen CH et al. PLoS ONE 
8(11):10.1371). And after implantation, the scaffold must not provoke any 
undesirable immune reaction that may reduce healing or cause rejection by 
the body (Fergal, 2011). 
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Biodegradability: It is one of the crucial factors for scaffolds 
because by gradual degradation it helps to make space for growing tissues to 
deposit their own matrix (J.E. Babensee, 1998) and hence, avoids the 
necessity of second surgery to remove the implant. That is an ideal scaffold 
should be able to degrade with time in vivo, but at a rate almost proportional 
to the rate of the tissue formation. The degradation products of the 
biodegradable materials should be non-toxic to other tissues in vivo. There 
are two distinct modes of degradation. The first type of biodegradation is 
bulk erosion, erosion happens throughout the device and it occurs when the 
rate at which water penetrates, exceeds the rate of conversion of the polymer 
into water soluble materials (J.C. Middleton, 2000 & J.Kohn, 1996).The 
second is, surface erosion that occurs when the rate at which water penetrates 
the device is very slower than the rate of conversion of the polymer into 
water soluble materials (J.C. Middleton, 2000 & J.Kohn, 1996).Surface 
erosion happens layer by layer while maintaining its bulk integrity. It is often 
referred to as bioerosion rather than biodegradation (M.E. Gomes. 2004). 
Structural requirements: An ideal scaffold should have void 
volume for vascularization, neo tissue formation & remodeling, necessary to 
facilitate host tissue integration upon implantation (B.P. Chan, 2008). 
Biomaterials should be processed to provide a highly porous structure with 
interconnected porosity for transporting oxygen, nutrients and waste 
metabolites in and out of the scaffold without significantly compromising the 
mechanical stability of the scaffold (B.P. Chan, 2008). A scaffold with too 
small pore size may enact the cells to penetrate the scaffold initially and 
subsequently to migrate through these pores to the other regions of the 
scaffolds where the too large pore size may inhibit the effective neo-tissue 
regeneration by disabling the cells to bridge pores during cell proliferation 
(Edwards, 2004). Generally smooth surfaces exhibit less cell adhesion than 
rough surfaces. Young’s modulus as well as Yield, compressive, & flexural 
strength is greatly related to the pore volume and size i.e. mechanical 
properties generally reduces with increasing porosity. 
Mechanical Properties: An ideal scaffold should have enough 
mechanical strength to retain shape, to support growing tissues, & withstand 
in vivo forces (Edwards, 2004). During implantation it must possess enough 
strength to allow surgical handling. 
Manufacturing technology: During developing tissue engineering 
scaffolds one should concern about the biomaterials and fabrication 
techniques. Another important consideration is to produce a large quantity of 
scaffolds at a relatively low or reasonable cost i.e. to turn them suitable for 
commercialization (Edwards, 2004). 
Cells:According to the source, cells are generally classified as 
follows:  
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Autologous cells: Obtained from the same individual to whom they 
will be re-implanted (Cherian, 2011). Transplantation of autologous cells 
minimizes the immune complications like pathogen transmission and 
immune rejection which makes them an ideal source for use in tissue 
engineering (Tran, 2003). However, in some cases, this type of cells might 
be unavailable like genetic diseases(Cherian, 2011). Also very ill patient, 
severely burnt patient and even an elderly person may lack affordable 
quantities of cells to establish useful cell lines (Cherian, 2011). Further, 
Autologous solutions may not be very quick (Cherian, 2011) & are not cost 
effective (Knight, 2004). 
Allogenic cells: Cells are isolated from the body of a human donor 
i.e. from the same species but are immunologically inidentical (Kim et al, 
2005). Autologous cells offer some advantages like uniformity, 
standardization of procedure and are cost effective (Kim et al, 2005). 
Xenogenic cells: Cells are obtained from donors of different species 
(Cherian, 2011 & Kevin, 2014). For instance, animal cells like bovine, 
equine, and porcine tissues have been used extensively for cardiovascular 
implants (Kevin, 2014). 
Isogenic or Syngenic cells: Isolated from clones, twins who are 
genetically identical (Cherian, 2011). 
Stem cells: Stem cells are undifferentiated cells (Cherian, 2011), 
have the ability to self-renewal, & cell potency. Stem cells, according to their 
plasticity or developmental versatility, can be classified into three groups: 
(Cherian, 2011 & www.aaas.org) 
1. Totipotent stem cells: Totipotent stem cells are early embryonic 
cells of 1-3 days from oocyte fertilization. It has the potential to form 
all cell types in a body, also extra embryonic or placental cells. An 
entire functional organism is possible by this type of cell. 
2. Pluripotent stem cells: The totipotent stem cells are continues to 
divide & specialized further into pluripotent stem cells, 
approximately 4days after fertilization & up to 14th days. Pluripotent 
stem cells can differentiate into any of the three germ layers: 
endoderm, mesoderm, and ectoderm but like totipotent stem cells can 
not give rise to an entire organ. 
3. Multipotent stem cells: Embryonic cells, specialized further from 
the pluripotent stem cell division. Multipotent stem cells can 
differentiate into multiple but limited cell types. 
 Stem cells are broadly divided into two groups:  
1. Adult stem cells/Somatic stem cells: Adult stem cells are 
multipotent stem cells (Pandit N, 2011),found in specific niches or 
tissue compartments. They are available in various sources like 
trabecular, bone, muscle, blood, bone marrow, liver, skin, cornea, and 
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retina of the eye, dental pulp, GI tract, & pancreas (Kim et al, 2005). 
At least twenty major categories of adult stem cells have been 
identified in mammals (Kim et al, 2005). Recently some evidence 
proves that adult stem cells have greater plasticity than was thought 
before.  
2. Embryonic stem cells: They are totipotent cells (Pandit N, 2011) 
and isolated from the inner cell mass of blastocysts (Kim et al, 2005). 
But its use has been limited to the tissue engineering research field 
due to ethical concerns regarding use of human embryonic stem cells 
and the potential tumorogenicity & immunological incompatibilities 
(Pandit N, 2011). 
Signaling molecules: Signaling molecules provide stimuli for cell 
adhesion, growth, differentiation, vascularization, & other functions. There 
are several kinds of signaling molecules used such as growth factors, 
cytokines, hormones, small molecules like neurotransmitters (Aneta, 2010 & 
Jin Gao, A neuroinductive biomaterial based on dopamine. 103(45):16681-
86), proteins, morphogenes, iRNA & e.t.c. Among these signaling 
molecules, multifunctional proteins like growth factors and cytokines have 
studied more for tissue engineering applications (Aneta, 2010). 
Table 1: Functions of various growth factors. 
Growth Factor Abbreviation Functions 
Platelet-derived 
growth factor 
PDGF-AA 
PDGF-AB 
PDGF-BB 
Proliferation and chemoattractant agent for smooth 
muscle cells; ECM synthesis and deposition (Ruth R, 
2003). 
Epidermal growth 
factor EGF 
Proliferation of mesenchymal, epithelial, & fibroblast 
cells (Ruth R, 2003). 
Transforming 
growth factor-α TGF-α 
Migration and proliferation of keratino-cytes; ECM 
synthesis and deposition (Ruth R, 2003). 
Transforming 
growth factor-β TGF-β 
Stimulates recruitment & proliferation of mesenchymal 
cells, their differentiation into osteoblasts and /or 
chondrocytes, & ECM production (Bose, 2012). 
Fibroblasts growth 
factor 
aFGF/FGF-1 
bFGF/FGF-2 
Mesenchymal condensation, Osteogenic differentiation 
(Brochhausen, ISBN:978-953-307-079-7). 
Vascular endothelial 
growth factor VEGF 
Vascularization, ingrowth of osteoblasts & 
chondroblasts (Brochhausen, ISBN:978-953-307-079-
7). 
Bone 
morphogenetic 
protein 
BMP-2 
BMP-7 
Critical in embryonic skeletal development, bone 
formation, maturation, & repair. They differentiate and 
migrates bone forming cells (Bose, 2012). 
Insulin-like growth 
factor IGF 
Regulates several key cellular process, including 
proliferation, movement, and inhibition of apoptosis 
(Bose, 2012). 
Hepatocyte growth 
factor HGF 
Participate in the bone remodeling process(Pandit N, 
2011). 
 
Bioreactor: In tissue engineering, a bioreactor, used for 3D cell 
culture is a device that provides the pre-defined chemical, biochemical, 
physical, and mechanical environments for the seeded scaffolds so that cells 
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can proliferate & differentiate to form neo-tissues in vitro (Hua, 2007). 
However enough oxygen and nutrient supply to the growing thick tissue with 
removal of waste metabolites, specifically from the center of the construct, 
has made the 3D dense tissue formation a real challenge because most 
bioreactors can not deal with these requirements (Hua, 2007 & Leor J, 2005). 
For instance, human heart muscle is about 1cm thick, but in a bioreactor, 
tissue growth typically stops when it is about 100 micrometer. Moreover, 
cells at the innermost position are too far from the supply of fresh growth 
medium (Leor J, 2005). To overcome the diffusional problems, researchers 
have developed hollow fiber membrane bioreactors so that the membrane 
network can replicate the blood capillary system (Hua, 2007). 
 
Biomaterials 
Metals: Porous metallic scaffolds are considered as the most suitable 
implants for hard tissue engineering in load bearing areas as metals have 
superior fatigue resistance (Garrett, 2006) and high compressive strength, 
required for load bearing applications such as femur, vertebra, skull, & 
mandible reconstruction, replacement of hip and knee bone e.t.c. However, 
metallic scaffolds have some limitations: (1) lacking of biological 
recognition on the material surface or bioactivity (XIAO, 2012), considered 
as the main disadvantages of metallic scaffolds, (2) Biomolecules can not be 
integrated into the metallic scaffolds (Bose S, 2012), (3) Metallic scaffolds 
are generally not biodegradable (Bose S, 2012),(4) The another concern with 
metallic scaffolds is the possible release of toxic metallic ions (Bose S, 2012) 
or particles through corrosion or wear, (5) The control of architecture of 
porous metallic scaffold is another problem. For some metals that are too 
weak, it is difficult to create a controlled porous structure while some 
materials are too stiff to be arranged into certain architectures (Kelly, 2009). 
An essential requirement of already established biocompatible metal for use 
in tissue engineering scaffold is the surface modification which reduces some 
of the limitations of metallic scaffolds (XIAO, 2012 & Kelly, 2009). 
 
Non –biodegradable metals 
 Ti and Ti alloys: Porous Ti and Ti alloys are considered as the most 
promising biomaterials for bone tissue engineering scaffolds due to their new 
bone tissue in-growth capability and lower modulus of elasticity similar to 
that of natural bone (Li Y, 2009). Ti alloys specifically Ti-6Al-4V is widely 
used in various orthopedic applications because it possesses good 
biocompatibility & better mechanical properties than conventional stainless 
steel, Co-based alloys, & even more than pure titanium (Kelly, 2009 & Li Y, 
2009). But Ti-6Al-4V contains an element, vanadium which, when isolated 
has possessed cytotoxic outcomes that has led the researchers to develop new 
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β- Ti alloys with nontoxic elements like Nb, Zr, & Ta (Kelly, 2009). Porous 
Ti-6Ta-4Sn alloy scaffold fabricated with a Space Holder Sintering method 
was studied by Liu et al as a great feasibility in an orthopedic implant 
because of its excellent biomechanical properties (Liu Y, 2009). Though Ti 
is found to be well tolerated and bio-inert it does not bond directly to bone 
unless the application of bioactive materials that induce a specific biological 
activity i.e. form a biologically active bone-like apatite layer on the material 
surface in vivo (Garrett, 2006). Some growth factors like TGF-β, BMP-2, 
often applied via Ti scaffold to accomplish craniofacial reconstruction or 
augmentation of bone, enhanced regeneration of bone e.t.c. (Kelly, 2009 & 
Jansen, 2005). Ti and Ti alloys are non-ferromagnetic, so titanium implanted 
patient may safely be examined with magnetic resonance imaging (Kelly, 
2009). 
Nitinol: Nitinol (metal alloy of Ni & Ti with roughly equiatomic 
parts of Ni and Ti) exhibit a mixture of unique properties where two closely 
related properties are thermal shape memory effect and superelasticity, & 
other properties include enhanced biocompatibility, and high damping 
properties (Garrett, 2006 & Greiner, 2005). These properties made it one of 
the most promising metallic biomaterials. Shape memory effect allows the 
researchers to create such a scaffold that can change its shape after 
implantation, initiated at the temperature of the human body (Kelly, 2009). 
Tantalum(Ta): Porous Ta possesses some unique mechanical and 
physical properties. Its unique mechanical properties are mainly because of 
its high porosity (>80%) with fully interconnected pores which allows rapid 
bone in-growth (Kelly, 2009). It has a low modulus of elasticity close to that 
of natural bone like subchondral and cancellous bone which leads to better 
load transfer and ultimately less stress shielding phenomenon (Kelly, 2009). 
Like Ti, Ta is a non-ferromagnetic, do not cause harm to the patient with Ta 
implant undergoing MRI units. Ta is biologically inert so it is restricted to 
bond directly to the bone. This obstacle can be overcome by thermal 
processing of porous Ta in an alkaline environment which forms an 
extensive hydroxyapatite layer on its surface (Christos, 2012). 
 
Biodegradable metals 
 Magnesium(Mg): Mg and its alloys have been gaining particular 
interest as promising biomaterials for bone tissue scaffold due to their 
superior mechanical properties, fast corrosion (F. Witte, 2007 & Renáta, 
2013) in physiological solution, & non-toxic corrosion by-products. Mg and 
its alloys are very light weight metals having density 1.74-2 g/cm 3 closer to 
that of natural bone (1.8-2 g/cm 3 )(M.P. Staiger, Biomaterials 27:1728-
1734). Mg has greater fracture toughness and modulus of elasticity ranging 
from 41-45 GPa is closer to the bone which is necessary to avoid stress 
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shielding effect (A.H. Yusop, 2012). Addition of alloying elements and also 
some thermo-mechanical manufacturing process may improve the 
mechanical properties of Mg alloys (A.H. Yusop, 2012). However there is a 
concern about the use of pure Mg which corrodes very rapidly in the 
physiological environment. So Mg implant may lose its mechanical and 
structural integrity before completely healing the tissue (Renáta, 2013). In 
addition, this rapid corrosion reaction produces  H 2 at a higher rate that is 
difficult for the host tissue to deal with. To control the corrosion rate some 
measures have taken like provided with ceramic coating, titanium coating or 
the use of Mg alloys (A.H. Yusop, 2012).    
Iron(Fe): Fe exhibit high mechanical strength & corrodes very 
slowly which makes them suitable for higher load carrying implants (P. 
Quadbeck, 2007). It has been tested in vivo as biodegradable metal with no 
toxicity during 18 months of study (A.H. Yusop, 2012). The corrosion rates 
and mechanical properties could be increased by various alloying elements 
(Renáta, 2013).Chou DT et al have assessed the 3D printed Fe-30Mn (wt.%) 
scaffold as a bone scaffold material where 3D printed parts were maintained 
an open porosity of 36.3% and they found that 3D printed Fe-Mn corrodes 
significantly more rapidly than pure iron. The tensile mechanical properties 
were similar to that of natural bone and the scaffolds also possessed good 
cell infiltration & in vitro cytocompatibility. This preliminary study has 
made the Fe-Mn alloy a promising biomaterial for craniofacial biomaterial 
applications (Chou DT, 2013). 
 Ceramics: Ceramics are not generally used for soft tissue 
engineering. Ceramic scaffold possesses many aspects like being bioactive, 
biocompatible, biodegradable, mechanically stiff (Young’s modulus) (Qizhi, 
2012), less elastic and brittle (Qizhi, 2012). They also exhibit shaping 
difficulties. Bioceramics can be classified into the following three groups: 
(Shikinami, 1999) 
1. Bioinert groups. E.g. alumina and zirconia. 
2. Surface bioactive groups. E.g. high temperature sintered 
hydroxyapatite(s-HA), bioglass. 
3. Bioresorbable groups. E.g. low temperature sintered 
hydroxyapatite(u-HA), α-Tricalcium Phosphate (α-TCP), β-TCP, 
octacalcium phosphate (OCP), tetracalcium phosphate (TTCP).  
 For bone tissue engineering, various calcium phosphates (CaPs) 
specially HA, β-TCP, & biphasic calcium phosphate, BCP (mixture of HA & 
β-TCP) have long been studied as porous scaffold materials (Burg, 2000 & 
Hench, 1993). As natural bone consists of large amounts of HA (Ca 10 (PO4) 
6 (OH)2 ), so it might seem ideal to use HA, β-TCP as they closely mimic the 
chemical and crystalline nature of the mineral phase of the native bone (Q 
Chen, 2008 & Jarcho, 1981) and hence, will be biocompatible. HA is known 
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to its bioactivity, biocompatibility, non-toxicity, non-inflammatory, 
osteoconductivity, & biodegradability. In comparison with β-TCP, HA 
degrades slowly (Mohamed, 2011) (the degradation rate is generally ordered 
as following: OCP> α-TCP > β-TCP > u-HA>> s-HA (Yang, 2001)) & after 
implantation undergoes little conversion to a bone like material 
(Martin,1993). However, for the same porosity β-TCP scaffolds often exhibit 
lower mechanical strength than HA scaffolds, making them difficult for use 
in load bearing applications (Mohamed, 2011) . The degradation rate and 
other properties can be manipulated by varying HA to β-TCP ratios in BCP 
(Mohamed, 2011). In recent years, researchers have shown that dopant 
addition in the scaffolds of CaPs can control the biocompatibility, 
densification behavior, dissolution rates, & mechanical strength (Bose, 2011 
& Aneta, 2010). 
 
Figure 2: Calcium Phosphate based scaffold (Randall, 2004) 
 
Bioactive glasses have already shown their excellence as promising 
biomaterials for tissue engineering due to their ability to support bone cell 
growth, bonding to both hard and soft tissues (Min Wang, 2006), capability 
to repair defect sites & controllable degradation rate in vivo. Glass 
compositions as well as the microstructure of the scaffolds are important 
factors that determine the degradation rate & conversion to an HA-like 
material, mechanical properties and response to cells. Bioglasses, doped with 
various elements such as Cu, Zn & Sr, promotes the healthy bone growth 
(Hoppe, 2011). Recently researchers have shown that bioglass can enhance 
angiogenesis (formation of blood vessels), critical to tissue engineered 
constructs (M.E. Gomes , 2004 & Mohamed, 2011) and soft tissue wound 
healing (Mohamed, 2011).And this capacity of bioglasses has provided an 
alternative approach to the use of expensive growth factors for stimulating 
neovascularization of engineered tissues (Mohamed, 2011). 
Silicate bioactive glasses: The composition of 45S5 glass is 45% 
SiO2, 6% P2O5, 24.5% CaO, 24.5% Na2O & the low SiO2 content (<55% 
SiO2), high content of network modifiers like Na2O & CaO, high CaO/P2O5 
ratio contributes to the bioactivity of 45S5 glass (Mohamed, 2011). 45S5 
glass has long been established as highly bioactive, biocompatible (Wilson, 
1981), & biodegradable. It is considered as class A bioactive materials 
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(Hench, 2002) that are both osteogenetic and osteoconductive while class B 
bioactive materials (like HA) possess only osteoconductivity (Q Chen, 
2008). In contact with the body fluid, 45S5 glass forms HCA (carbonate 
substituted hydroxyapatite which is similar to the mineral constituent of the 
bone) layer on its surface that significantly promotes osteoblast activity. As a 
porous 3D scaffold material 45S5 glass has some limitations like processing 
difficulties into a scaffold, low mechanical strength, slow degradation rate & 
conversion to an HA-like material (Mohamed, 2011). But it has recently 
been discovered that during scaffolding 45S5 glass can be heated to high 
temperatures (>950°c), to make a mechanically strong crystallize phase 
(bioactive glasses are amorphous while glass ceramics possess crystallize 
structure) that can convert to a biodegradable, amorphous calcium phosphate 
at the body temperature & in a biological environment (Chen QZ, 2006). 
This process enables the mechanical competence and biodegradability to be 
incorporated in a single scaffold, making it promising as tissue engineering 
scaffold (Q Chen, 2008). Compared to 45S5 glass, 13-93 bioactive silicate 
glass has slower degradation rate (& conversion to an HA-like material) and 
has better processing characteristics by viscous flow sintering (Mohamed, 
2011). 
Borate bioactive glass: Researchers have shown that borate or 
borosilicate bioactive glasses promote cell proliferation and differentiation in 
vitro, as well as tissue infiltration in vivo (Mohamed, 2011).Compared to 
45S5 or 13-93 glass, borate bioactive glasses degrade faster and more 
completely convert to an HA-like material because of their lower chemical 
stability (Huang, 2006). The degradation rate can be controlled by 
manipulating the glass composition (Huang, 2006 & Yao A, 2007). 
However, there is a concern about the toxicity of boron released into the 
solution as borate ions (BO3) −3  (Mohamed, 2011).  
Phosphate Bioactive glass: (Mohamed, 2011) Phosphate bioactive 
glasses are based on P2O5-glass forming networks where CaO & Na2O acts 
as network modifiers. These glass show a chemical affinity towards bone 
because of their constituent ions are present in the organic mineral phase of 
the bone. The degradability can be controlled by modifying their 
composition, & this flexibility has made it potential resorbable biomaterials 
for tissue engineering. 
Natural Polymers: Natural polymer based scaffolds show excellent 
bioactivity, biodegradability, but poor mechanical properties which reveal 
their successful use in soft tissue engineering & not for load bearing 
applications. Moreover, there is immunological concern associated with 
naturally derived polymers. Scaffolding natural polymeric materials with 
homogeneous & reproducible structures are other problems which limited 
their wide applications (Fergal, 2011). 
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Collagen: Collagen is considered as an ideal choice for tissue 
engineering scaffolds because it is the major fibrous protein in the 
extracellular matrix (ECM), & provides strength and structural integrity to 
connective tissues including skin, bone, tendons, cartilage, blood vessels, & 
ligaments (Amoabediny, 2011). Twenty seven types of collagen have been 
identified (Amoabediny, 2011) where 80-90% of the collagen in the body 
consists of type 1, 2, & 3 (Chunlin, 2004).  In tissue engineering, collagen 
scaffolds are used in various forms such as porous sponges, thin sheets or 
gels (Dhandayuthapani, 2011& Amoabediny, 2011). Collagen scaffolds 
possess the excellent biocompatibility, high porosity & permeability, 
hydrophilicity, biodegradability, but poor mechanical strength for bone tissue 
engineering in minimally weight bearing applications. However, the 
degradation rate, compressive and tensile strength can be enhanced by 
physical and chemical cross-linking methods (Cuy J, 2004).  
Chitosan: Chitosan, derivative of chitin, is a linear polysaccharide 
polymer composing copolymers of β (1-4)-glucosamine & N-acetyl-D-
glucosamine. Chitin exists in the exoskeleton of crustaceans (such as crabs, 
shrimps), cuticles of insects & cell walls of bacilli (Amoabediny, 2011). 
Chitosan has gained special attention from researchers owing to its 
biocompatibility, low toxicity, biodegradability, controllable mechanical and 
structural properties, & capability of being processed in many forms, sizes 
and shapes. But pure chitosan as a polymeric tissue engineering scaffold is 
limited because of their weak mechanical properties (Mohammad, 2012  & 
Amoabediny, ISBN:978-953-307-609-6) and inconsistent behaviour with 
seeded cells (Madihally, 1999). However, chitosan can be physically & 
chemically modified (Mohammad, 2012), and produce materials with wide 
range of properties. 
Alginate: Alginate is a linear polysaccharide isolated from brown sea 
algae. It holds to a family of linear block polyanionic copolymers consisting 
of (1-4)-linked β-D-mannuronic acid (M fragments) & (1-4)-linked α-L-
guluronic acid (G fragments) residues (BouhadirKH, 2001 & Sutherland, 
1991). Alginate can form stable and well characterized hydrogels in the 
addition of certain divalent cations (e.g. Ca2+, Sr2+, Ba2+ (Wang, 1993 & 
Honghe. 1997), except Mg2+ (BouhadirKH, 2001)) at low concentrations. To 
prevent immune responses after implantation alginate must undergo 
extensive purification (Willerth S.,2007). Alginate possesses 
biocompatibility, hydrophilicity, non-cytotoxicity, biodegradability, & also it 
is thermally stable and relatively economical. But some drawbacks have 
limited their applications in tissue engineering such as weak mechanical 
properties, poor cell adhesion (for highly hydrophilic nature) and 
uncontrollable degradation (BouhadirKH, 2001). These limitations can be 
improved by mixing with other materials like hydroxyapatite and also with 
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natural polymers, chitosan and agarose (Amoabediny, ISBN:978-953-307-
609-6 & Sutherland, 1991).  
Agarose: Agarose is a polysaccharide extracted from red algae and 
seaweed. It is a linear polymer composed of D-galactose and 3,6-anhydro-L-
galactopyranose linked by α-(1-3) & β-(1-4) glycosidic bonds. Agarose is 
purified from agar (which has two principle components, agarose and 
agaropectin), by removing agar’s one component, agaropectin. The 
properties of agarose i.e. good mechanical strength and capacity to retain 
chondrocytes phenotype make it suitable for the scaffolds of cartilage tissue 
engineering. Agarose hydrogels are popular owing to their biocompatibility, 
native tissue like viscoelastic mechanical properties and ease of casting into 
complex shapes and sizes (Bose corporation, 2012). 
Fibrin: Fibrin is a fibrous, non-globular protein, & is a critical blood 
component involved in the hemeostasis (Ahmed, 2008). Fibrin hydrogel is 
formed by combining commercially available fibrinogen (fibrinogen is a 
soluble, plasma glycoprotein, consisting of six chains-two α, two β, & two γ 
chains, linking by disulfide bonds (Wnek GE, 2002)) and thrombin (Wnek 
GE, 2002 & Ahmed, 2008). One advantage of fibrin is that it can be 
autologously sourced (Linnes, 2007). Fibrin scaffolds are biodegradable, 
biocompatible, non-toxic, easy processable with various size and shape, & 
fibrin is relatively cost effective than synthetic polymers or collagen gels 
(Ahmed, 2008). The function of fibrin scaffold can be improved by 
incorporating bioactive peptides and growth factors through heparin-binding 
delivery system (Ahmed, 2008). The mechanical properties of fibrin scaffold 
can be controlled by varying concentrations of components, according to the 
needs of surrounding or encapsulated cells. Biodegradation can be managed 
(Wozniak, 2003) with the help of fibrinolysis inhibitors (Cholewiaski, 2009) 
or fiber cross-linkers.   
Fibronectin: Fibronectin, exists outside cells and on the cell surface, 
in blood plasma & other body fluids (Amoabediny, ISBN:978-953-307-609-
6), is a high molecular weight glycoprotein of the ECM, that can bind other 
ECM components like collagen, fibrinogen, & glycosaminoglycans 
(Amoabediny, ISBN:978-953-307-609-6). Fibronectin is considered as a key 
component of the ECM and it involves in both the structural integrity and 
functional properties of the living tissues. It contributes to cell adhesion, 
proliferation, migration, & differentiation (Stoffels, 2013). 
Synthetic polymers: Numerous synthetic polymers have been tried 
to produce scaffolds because of their several advantages as a scaffold 
material and also due to their availability. Synthetic polymers can be 
biodegradable and non-biodegradable. Synthetic polymeric materials can be 
fabricated with a tailored architecture and properties (e.g. porosity, 
degradability, & mechanical properties), according to their applications. That 
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means they can be produced under controlled conditions with large uniform 
quantities and long shelf life (Dhandayuthapani, 2011). However there is a 
risk of rejection of these polymeric scaffolds owing to their reduced 
bioactivity. During the degradation process, formation of acidic products & 
consequently lowering the local pH is a common problem with synthetic 
polymers which can result in diminishing mechanical strength of material 
and cell-tissue necrosis. 
Poly (α-hydroxy esters): 
1. Polylactic acid (PLA): PLA is the biodegradable, thermoplastic 
aliphatic polyester. The presence of pendant methyl group on the alpha 
carbon of PLA differentiates it physically, mechanically or chemically from 
the structurally very similar PGA (Yang S, 2001). Due to this structure 
which causes chirality; & so several distinct L, D, & DL isomers are possible 
(Yang S, 2001). PLLA is resulting from polymerization of L, L-lactide. 
PLLA has a semicrystalline structure (around 45%) with glass transition 
temperature ranging from 60-65°C,melting temperature from 170-180°C and 
tensile modulus between 2.7-16 GPa. The melting temperature and heat 
deflection temperature of PLLA can be increased by physically blending the 
polymer with PDLA (Poly-D-lactide) in which they form a highly regular 
stereocomplex with increased crystallinity, where (Yang S, 2001) PDLLA 
with a more or less random distribution of the stereo sequences is an 
amorphous material with a glass transition temperature between 50-60°C, 
depending on molecular weight. PDLLA degrades faster than PLLA if all 
other conditions remain same (Yang S,2001). Y.M.Lin et al studied the 
feasibility of growing lung cells on PDLLA scaffolds (scaffolds in two 
forms: polymer discs and 3D foams) to engineer pulmonary tissue for human 
implantation & their study has been demonstrated that PDLLA is nontoxic to 
pneumocytes and it actively supports their growth (Lin YM, 2006) 
2.Poly glycolic acid (PGA): PGA is the simplest, linear aliphatic 
polyester prepared by polycondensation or ring-opening polymerization, 
starting from glycolic acid. PGA exhibits an elevated degree of crystallinity 
(generally 45-75%) with glass transition temperature ranging from about 25-
65°C, & melting temperature between 185-225°C (Yang S, 2001). PGA has 
a good thermal stability, as an absorbable material (Shalaby, 1994). Because 
of its highly crystalline nature, PGA is not soluble in water. High molecular 
weight form of PGA is not soluble in almost all common organic solvents 
(exceptions are highly fluorinated organic solvents like 
hexafluoroisopropanol(HFIP) & hexafluoroacetone sesquihydrate) while low 
molecular weight oligomers differ in their physical properties and show more 
solubility. 
3.Poly (lactic-co-glycolic) acid (PLGA): PLGA is synthesized by 
random ring-opening co-polymerization of glycolic acid and lactic acid 
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monomers. It has a glass transition temperature ranging from 45-55°C. 
PLGA possesses unique properties like good mechanical strength, excellent 
biocompatibility, low toxicity and immunogenicity, & versatile degradation 
kinetics (M S Muthu, 2009 & PLGA-PEG, 2003). The properties of PLGA is 
tailored by vayring the monomer ratios and molecular weight 
(Polyscitech.com/PLGA/PLGA.php & M S Muthu, 2009). PLGA prepared 
from L-poly lactide (L-PLA) and poly glycolide(PGA) are crystalline in 
nature while PLGA from D, L-PLA & PGA are amorphous (M S Muthu, 
2009). Generally PLGAs show crystallinity if there is a higher percentage of 
lactide units in the co-polymer composition. The mechanical strength, degree 
of crystallinity, melting temperature and glass transition temperature of the 
polymers are directly influenced by the molecular weight of the polymer. 
The higher the molecular weight, the greater the mechanical strength found. 
Also researchers have found that the glass transition temperature of PLGA 
decrease with the decrease of lactide content in the monomer ratios with 
decreasing molecular weight (M S Muthu, 2009). 
4.Poly (e-caprolactone) (PCL): PCL is relatively inexpensive, 
highly elastic, and an aliphatic polyester which is established as 
bioresorbable and biocompatible. Semicrystalline PCL polymer is made by 
ring-opening polymerization of e-caprolactone (Yang, 2001). Melting 
temperature of the polymer is around 60°C & a glass transition temperature 
of -60°C. This polymer is degraded by hydrolysis of its aliphatic ester 
linkages in physiological environments (Yang, 2001& Amoabediny, 
ISBN:978-953-307-609-6). The degradation time of PCL homopolymer is 
very slow which can be accelerated by synthesizing co-polymers. For 
example, co-polymers of e-caprolactone with D, L-lactide have produced 
materials with faster degradation rates (Yang, 2001). Not only controllable 
degradation rates, PCL co-polymers (co-polymerized with other 
hydroxyacids or polymers like glycolide or lactide) also provide better 
control over mechanical properties without sacrificing biocompatibility 
(Qizhi, 2012). PLA, PGA, PCL are rigid and poorly flexible while PCL co-
polymers with lactide or glycolide are elastomeric, can provide sustainable 
elasticity & structural integrity (Christian, 2007) that are thought to be 
mechanically more advantageous than thermoplastic polymers because 
elastic stretchability is an important mechanical characteristic of living 
tissues including collagens of different bone types (Qizhi, 2012). 
Poly β-hydroxy butyrate: Poly (hydroxyalkanoate)s (PHAs) are 
bioderived, biocompatible, & biodegradable thermoplastic polyesters that are 
produced by various microorganisms (Leng J, 2010). Among various PHA, 
PHB is extensively studied for bone tissue engineering (Leng J, 2010), which 
is a linear homopolymer of (R)-β-hydroxybutiric acid that forms crystalline 
cytoplasmic granules in the wide variety of bacteria strains (Amoabediny, 
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ISBN:978-953-307-609-6). The properties of this polymer are closer to that 
of polypropylene, possesses low thermal stability with glass transition 
temperature in the range of -5 to 20°C & melting temperature between160-
180°C. After implantation, it degrades slowly at body temperature and 
produces a non-toxic metabolite, secreted through the urine (Mosahebi, 
2001). The mechanical properties, biocompatibility, & biodegradability of 
this polymer can be manipulated by blending, & surface modification or 
composition with other polymers, enzymes, or inorganic materials to 
enhance the range of clinical applications (Leng J, 2010 & Sérgio, 2006). 
However, high crystallinity, high fragility, poor processability (Sérgio, 2006) 
or the time consuming extraction (Leng J, 2010) of these types of bacterial 
culture polymers has limited their applications. 
Poly(glycerol sebacic acid) (PGS): PGS, also called bio-rubber 
(Amoabediny, ISBN:978-953-307-609-6), can be obtained by 
polycondensation of glycerol & sebacic acid. It has ester cross-links & 
hydroxyl groups, directly attached to its backbone (Wang, 2002). 
Appropriate cross-link density makes PGS tough and elastomeric while 
hydroxyl groups make it highly hydrophilic (Wang, 2002). PGS is 
biocompatible both in vitro and in vivo (Wa Christian, 2007 & Wang, 2002).  
PGS features robust mechanical properties, surface erosion biodegradation. 
The degradation rate, hydrophilicity, and other properties can be tailored by 
grafting hydrophobic moieties to the hydroxyl groups (K.N. Jayachandran, 
2000 & A.Laschewsky, 2001). However, harsh processing conditions like 
higher temperatures,& longer reaction times may limit its ability to 
polymerize directly in a tissue or to incorporate cells or temperature sensitive 
molecules (Christian, 2007).  
Poly (2-hydroxyethyl methacrylate): It is a soft, flexible, highly 
biocompatible, & water-absorbing plastic widely used to make soft contact 
lenses. Hydro soluble monomer, HEMA, can be polymerized (under various 
circumstances) at low temperatures (-20 to +10°c) and can be used to prepare 
various hydrogels (Amoabediny, ISBN:978-953-307-609-6). Though HEMA 
is not biodegradable (Mabilleau, 2004) but this property can be achieved 
through cross-linking with PCL (Rice, 2006) which is hydrolytically and 
enzymatically degradable polymer. pHEMA is an attractive and potential 
synthetic polymer for cardiac and other tissue engineering scaffolds because 
of its elasticity, reasonable mechanical strength, & easy fabrication into 
numerous configurations.  
Polyphosphazenes: Polyphosphazenes are consisting of an inorganic 
backbone of alternating phosphorus & nitrogen atoms. Each phosphorus 
atom in the backbone is substituted for by two organic side groups, giving a 
wide range of polymer properties and this flexibility of polyphosphazenes 
have made them suitable for both hard and soft tissue engineering (Heta, 
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2011) like bone tissue, blood vessels, or tissue regeneration in the 
periodental cavity e.t.c. So by selecting proper side groups, polyphosphazene 
scaffolds with required properties and degradation rates can be fabricated 
(A.K. Andrianov, 2009). By altering the organic substituents, physico-
chemical properties, mechanical properties, biocompatibility, degradation 
rates with nontoxic degradation products can be tailored to a great extent 
(Heta, 2011). 
Polyurethane (PUs): PUs, containing the urethane (-NH-CO-O-) 
linkage, is typically produced by adding an isocyanate to a hydroxy group 
(Hetal, 2011). Segmented polyurethanes are block co-polymers comprised of 
macropolyols made soft segments linked together by diisocyanates and chain 
extenders made hard segments (Qizhi, 2012). Polyurethanes have been used 
for many years in biomedical applications owing to their tissue specific 
biocompatibility, excellent mechanical properties, biodegradability (Lamba, 
1998 & Santerre, 2005) & good processability. Their biological mechanical 
properties and degradation rates can be tuned (Heta, 2011) by modyfing the 
structure of soft or hard segments (Qizhi, 2012). Generally a high content of 
soft segments enhance the degradation rates (Pinchuk, 1094). Unlike the 
PGA, PLA, & PLGA the degradation behaviour of polyurethanes 
demonstrated no significant pH change in the microenvironment of their 
degradation products (Qizhi, 2012). But the degradation products could be 
toxic when aromatic diisocyanates are used which could be removed by 
replacing aliphatic diisocyanates (Lamba, 1998). 
Polyanhydrides: Polyanhydrides are a class of hydrophobic, surface 
eroding polymers (GUO BaoLin, 2014) consisting of anhydride bonds that 
connects repeat units of the polymer backbone chain. Polyanhydrides can be 
synthesized by melt condensation or solution polymerization and can be 
manipulated to meet desirable characteristics (GUO BaoLin, 2014). 
Aliphatic polyanhydrides have crystalline structure with melting temperature 
between50-90°C. Unsaturated polyanhydrides are highly crystalline where 
aromatic polyanhydrides are very hydrophobic (melting 
temperature>100°C), degrade slowly in the physiological environment and 
generates relatively insoluble degradation products. Anhydrides are useful as 
scaffold for functional soft tissue substitutes but modest Young’s modulus 
for entangled polyanhydrides network has limited their application in load-
bearing environment (Hetal, 2011). However, this shortcommings can be 
overcome by forming cross-linked networks with incorporated imides which 
has significant mechanical properties such as compressive strength which are 
in the intermediate rang of cortical and trabecular human bone (Hetal, 2011). 
Polyanhydrides are biocompatible and in vivo, degrades into non-toxic 
diacid monomers that can be eliminated from the body as metabolites (GUO 
BaoLin, 2014). Hydrolytic degradation can be controlled by manipulating 
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the polymer composition i.e. by adding hydrophilic monomer (such as 
sebacic acid) to the hydrophobic diacid building blocks of polyanhydrides. 
Poly (ethylene glycol) (PEG): PEG, the most commercially 
important polyethers, also known as polyethylene oxide (PEO) or 
polyoxyethylene (POE) depending on its molecular weight, refer to an 
oligomer or polymer of ethylene oxide (Amoabediny, ISBN:978-953-307-
609-6). PEG has some critical properties like good biocompatibility, non-
immunogenicity, & resistance to protein adsorption and cell adhesion 
(Amoabediny, ISBN:978-953-307-609-6) for which it has been an important 
type of hydrophilic polymers in biomedical applications including 
bioconjugation, surface modification, drug delivery, and tissue engineering 
(Junmin, 2010). For producing hydrophilic PEG hydrogels, PEG must be 
cross-linked and three major cross-linking methods are free radical 
polymerization of PEG acrylates, radiation of linear or branched PEG 
polymers, & specific chemical reactions such as condensation, Michael-type 
addition, Click chemistry,, native chemical legation and enzymatic reaction 
(Junmin, 2010). The most common approach for making PEG hydrogel with 
biocompatibility and non-toxicity is photopolymerization under mild 
conditions in the presence of cells and bioactive agents & is regarded as an 
advantageous method to fabricate hydrogel scaffolds in situ with spatial and 
temporal control (Amoabediny, ISBN:978-953-307-609-6 & Junmin, 2010). 
To meet the diverse needs in tissue engineering, bioactive molecules such as 
cell adhesion ligands, enzyme-sensitive peptides & growth factors have been 
incorporated into PEG hydrogels, to simulate one or more ECM biofunctions 
like cell adhesion, proteolytic degredation and growth factor-binding 
(Amoabediny, ISBN:978-953-307-609-6 & Junmin, 2010). 
Photodegradation, in contrast to hydrolytic degradation and enzyme-sensitive 
degradation, allows precise spatial and temporal control over degradation 
and release. 
Poly (propylene fumarate) (PPF): PPF is unsaturated linear 
polyester, undergoes hydrolytic degradation to fumaric acid & propylene 
glycol which are biocompatible and readily removed from the host body 
(Qizhi, 2012 & Leng, 2010). The degradation time and mechanical 
properties can be controlled by varying the PPF molecular weight and other 
components for PPF-based composites & that’s why preservation of the 
double bonds and control of molecular weight during synthesis of PPF are 
critical issues (Qizhi, 2012 & Leng, 2010). PPF is used in 3D scaffolds for 
guided tissue regeneration & a substrate for osteoblast cell cultures (Leng, 
2010). 
 Polypyrrole (PPy): PPy is a conductive polymer formed by 
polymerization of pyrrole. PPy is thoroughly investigated among other 
conductive polymers for biomedical applications due to its high electrical 
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conductivity, flexible preparation method, ease of surface modification, ion 
exchange property, excellent environmental stability, & both in vivo and in 
vitro biocompatibility (Anca-Dana Bendrea. J. of Biomaterials applications, 
Vol. 00-2011). Polypyrrole’s electronic properties are imparted by their 
conjugated structure of alternating c=c double bonds and c-c single bonds 
(C.B.Gumera, 2009). Its conductivity to allow signal transduction in nerve 
cells is one of the major advantages of polypyrrole, in nerve repair 
applications (Hetal, 2011). Though they are biocompatible (similar ti 
PLGA), but not cell adhesive and biodegradable which has been limited their 
application in nerve repair (C.B.Gumera, 2009). Cell adhesion behaviour has 
been improved by surface modification techniques. During the polymer 
synthesis process various biomolecules can be incorporated into polypyrrole 
as biodopants (Anca-Dana Bendrea. J. of Biomaterials applications, Vol. 00-
2011). Both electrical and biological activity of the resultant polypyrrole 
surface is affected by the various biomolecular based dopants. Researchers 
demonstrated that, cell responses can be modulated in terms of adhesion, 
growth, proliferation & differentiation by careful selection of the dopant 
anion (such as Cl-, Br-, or NO3-) ( Anca-Dana Bendrea. J. of Biomaterials 
applications, Vol. 00-2011). Most widely used biodopants were generally 
ECM derived components such as HE, HA, CSA, laminin-derived peptides, 
collagen, & other biomolecules like ATP, DNA, dermatan sulfate, NT3, 
NGF, BDNF, poly (L-lysine) were also entrapped in films, membranes or 
fibers of conjugated polymers (Anca-Dana Bendrea. J. of Biomaterials 
applications, Vol. 00-2011 & C.B.Gumera, 2009). Erodible and 
biodegradable polypyrrole polymers have been synthesized to alter the 
permanent nature of polypyrroles. PPy monomers, β-substituted, were 
chemically or electrochemically polymerized which showed in vitro 
biocompatibility by supporting the attachment and proliferation of 
mesenchymal progenitor cells where β-substituted polypyrroles were erroded 
on a pH-dependent manner and was controllable according to the 
composition of co-polymer (C.B.Gumera, 2009). 
Composites: Researchers have already made many composites: 
synthetic polymers with natural polymers, synthetic polymers with 
bioceramics, polymers with metals, metals with ceramics, e.t.c. For load-
bearing applications novel metal-polymer- ceramic composites have also 
been proposed (Kelly, 2009). Composites are necessary to obtain optimal 
biological, structural, mechanical and chemical properties of scaffolds. For 
example, in bone tissue engineering, bioceramics /polymers are commonly 
used composites. As native bone consists of a naturally occuring polymer 
and biological apatite, it might seem logical to use bioceramics /polymers 
composites. Also there are some other factors, sometimes biocompatibility 
and biodegradability of ceramics are found insufficient. Moreover, ceramics 
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are very brittle, and too stiff, while the polymers are found to be 
biocompatible and biodegradable with low mechanical strength (Budi 
Arifvianto, 2014). So this biological and mechanical mismatch can be 
overcome by blending the ceramics with natural or synthetic polymers. Some 
polymers like PGA, PCL, PLA degrades by hydrolysis, forming acidic 
products, & consequently lowering the local pH (Fergal, 2011). The massive 
release of acidic degradation products can cause strong inflammatory 
reactions which can avoid by incorporating CaPs or bioglass, because their 
basic degradation could buffer the acidic by-products of polymers and thus 
contributing to stabilize the pH of the environment surrounded by polymer. 
This is another important reason for proposing the composites (Qizhi, 2012). 
Hydrogels: Hydrogels are 3D networks comprising of highly 
hydrophilic polymers cross-linked via various chemical bonds and physical 
interactions which can absorb huge amounts of water (up to 99% (Hikmet 
Geckil, 2010)) or biological fluids & swell readily without dissolving (El-
Sherbiny, 2013). Hydrogels are soft and rubber like in the swollen state, 
mimic the specific aspects of microenvironments of tissues (Kaji H., 2011). 
Their highly hydrophilic natures are owing to the presence of hydrophilic 
moieties like amino, amide, carboxyl & hydroxyl groups distributed along 
the backbone of the polymer chain (El-Sherbiny, 2013).Various natural and 
synthetic polymers are used to prepare hydrogels. Synthetic polymers 
include poly (ethylene oxide) (POE), poly vinyl alcohol (PVA), poly (acrylic 
acid) (PAA), poly (propylene fumarate-co-ethylene glycol) (P(PF-co-EG)) 
(Jaenie, 2003), poly (2-hydroxyethyl methacrylate) (PHEMA) (Walker, 
1992), poly (N-isopropylacrylamide) (PNIPAAM) (Fujimoto, 2009). And 
representative naturally derived polymers are agarose, alginate, collagen, 
fibrin, gelatin, chitosan, hyaluronic acid (Jaenie, 2003) & silk. Hydrogels can 
be used to engineer almost every tissue in the body such as smooth muscle, 
bone and cartilage (Mekala, 2012). More recently, hydrogel scaffolds (Figure 
3) have gained much attention as a promising material to overcome various 
tissue engineering challenges such as vascularization, tissue architecture and 
simultaneous seeding of multiple cells (El-Sherbiny, 2013). 
 
Figure 3: (A) Hydrogel Scaffold, (B) Solid Polymeric Scaffold (Zohreh, 2012) 
 
 
European Scientific Journal   July 2014 edition vol.10, No.21   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
206 
Conclusion 
 Over the past few decades, critical improvements have been made in 
the field of biomaterials, even new and multifunctional biomaterials have 
been investigated. Though still some drawbacks associated with 
biomaterials, scaffold fabricating techniques, signaling factors, & cells are 
challenging the success of tissue engineering, but rapid progress in tissue 
engineering field and growing demand on regenerative medicine have made 
the researchers hopeful to be fully successful in the near future. 
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